4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-003748
CHIEF OPERATING OFFICER sold 14,000 shares at $19.57 ($273,980)
- CHIEF OPERATING OFFICER acquired 7,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessari Eben CHIEF OPERATING OFFICER | 2025-02-10 | Option exercise 10b5-1 | +7,000 | $3.80 | $26,600 | 95,975 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-02-10 | Sale 10b5-1 | −14,000 | $19.57 | $273,980 | 81,975 | D |
| Derivatives | |||||||
| Tessari Eben CHIEF OPERATING OFFICER | 2025-02-10 | Option exercise · Share Option 10b5-1 | −7,000 | 21,049 | D | ||
| Open-market sales · 14,000 sh · avg $19.57 · $273,980 | |||||||
Loading xslF345X05/form4-02122025_090204.xml…